Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study: Digestive and Liver Disease

R. D'Ambrosio, L. Pasulo, A. Giorgini, A. Spinetti, E. Messina, I. Fanetti, M. Puoti, A. Aghemo, P. Viganò, M. Vinci, B. Menzaghi, A. Lombardi, A. Pan, M.G. Pigozzi, P. Grossi, S. Lazzaroni, O. Spinelli, P. Invernizzi, F. Maggiolo, N. TerreniA.D. Monforte, P.D. Poggio, M.T. Taddei, S. Colombo, P. Pozzoni, C. Molteni, A. Brocchieri, S. Bhoori, E. Buscarini, R. Centenaro, M. Mendeni, A.E. Colombo, M. Di Marco, E. Dionigi, D. Bella, M. Borghi, M. Zuin, S. Zaltron, F. Noventa, D.S. Annalisa, P. Lampertico, S. Fagiuoli

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)190-198
Number of pages9
JournalDig. Liver Dis.
Volume52
Issue number2
DOIs
Publication statusPublished - 2020

Keywords

  • CKD
  • eGFR
  • Kidney
  • SVR
  • ribavirin
  • sofosbuvir
  • adult
  • aged
  • Article
  • chronic kidney failure
  • cohort analysis
  • drug efficacy
  • estimated glomerular filtration rate
  • female
  • hepatitis C
  • human
  • Italy
  • kidney function test
  • major clinical study
  • male
  • predictive value
  • priority journal
  • retrospective study
  • sustained virologic response
  • treatment duration

Cite this

D'Ambrosio, R., Pasulo, L., Giorgini, A., Spinetti, A., Messina, E., Fanetti, I., Puoti, M., Aghemo, A., Viganò, P., Vinci, M., Menzaghi, B., Lombardi, A., Pan, A., Pigozzi, M. G., Grossi, P., Lazzaroni, S., Spinelli, O., Invernizzi, P., Maggiolo, F., ... Fagiuoli, S. (2020). Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study: Digestive and Liver Disease. Dig. Liver Dis., 52(2), 190-198. https://doi.org/10.1016/j.dld.2019.11.006